养心氏片治疗气虚血瘀型心绞痛的疗效与成本-效果分析
2019-09-10吕瑞民王英臣
吕瑞民 王英臣
摘要 目的:观察养心氏片治疗气虚血瘀型心绞痛的临床疗效,分析治疗的成本效果。方法:选取2018年6月至2018年10月黑龙江中医药大学第一附属医院收治的辨证为气滞血瘀型心绞痛患者90例作為研究对象,随机分为对照组和观察组,每组45例。对照组采用常规西药治疗,观察组采用常规西药+养心氏片治疗,分别观察比较2组患者3个月内持续服用药物的临床疗效、心绞痛发作次数、复诊住院率、心电图疗效、成本-效果比及不良反应发生情况。结果:观察组总有效率95.6%,对照组为82.2%,2组比较差异有统计学意义(P<0.05);观察组心绞痛发作次数少于对照组,复诊住院率低于对照组,2组比较差异有统计学意义(P<0.05);观察组心电图改善疗效优于对照组(P<0.05)。成本-效果比分析显示:观察组费用196.28元,对照组为804.24元,观察组治疗效果所花费用较对照组少607.96元。2组不良反应发生情况比较,差异无统计学意义(P>0.05)。结论:观察组与对照组比较,加用养心氏片可以明显提高临床疗效,改善心电图,降低心绞痛的发作次数及复诊后住院率,有效降低治疗成本,且无不良反应增加。
关键词 心绞痛;养心氏片;临床疗效;心电图;成本-效果比
Abstract Objective:To observe the clinical effects and cost-effectiveness ratio analysis of Yangxinshi tablet in treating angina pectoris of qi deficiency and blood stasis syndrome.Methods:A total of 90 patients with angina pectoris of qi deficiency and blood stasis syndrome in the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine were randomly divided into an observation group(routine western medicine+Yangxinshi)and a control group(routine western medicine),with 45 cases in each group.The clinical efficacy,the number of angina attacks,the rate of re-visit hospitalization,the effect of electrocardiogram,the cost-effectiveness ratio,and adverse reactions between the 2 groups within 3 months were observed and compared.Results:After treatment,the total effective rate was 95.6% in the observation group and 82.2% in the control group,and the difference was statistically significant(P<0.05).The number of angina attacks and the rate of re-visit hospitalization in the observation group were lower than that in the control group.The improvement of electrocardiogram in the observation group was significantly better than the control group(P<0.05).The cost-effectiveness ratio was 196.28 yuan in the observation group and 804.24 yuan in the control group.The cost of the observation group was 607.96 yuan less than that of control group in the treatment effects.There was no difference in adverse reactions between the 2 groups.Conclusion:Compared with the control group,the observation group can significantly improve the clinical efficacy and ECG,reduce the incidence of angina pectoris and hospitalization rate after re-visit,and effectively reduce the cost of treatment,and no more obvious adverse reactions were observed.
Key Words Angina pectoris; Yangxinshi Tablet; Clinical efficacy; electrocardiogram; Cost-effectiveness ratio
中图分类号:R256.22 文献标识码:A doi:10.3969/j.issn.1673-7202.2019.07.038
冠心病心绞痛是由于冠状动脉粥样硬化导致血管腔狭窄或闭塞和(或)冠状动脉功能性改变(痉挛)导致心肌急剧的、暂时的缺血与缺氧所引起,且以发作性胸痛或胸部不适为主要表现的临床综合征,属中医学“胸痹”“心痛”范畴[1]。临床治疗冠心病心绞痛除PCI手术等血运重建术外,药物治疗仍是主要手段之一。……
